Roger Pomerantz - Net Worth and Insider Trading
Roger Pomerantz Net Worth
The estimated net worth of Roger Pomerantz is at least $158,777 dollars as of 2024-04-25. Roger Pomerantz is the President and CEO of Seres Therapeutics Inc and owns about 213,976 shares of Seres Therapeutics Inc (MCRB) stock worth over $158,770. Roger Pomerantz is the Director of Rubius Therapeutics Inc and owns about 100 shares of Rubius Therapeutics Inc (RUBY) stock worth over $6. Roger Pomerantz is also the Director of ContraFect Corp and owns about 80 shares of ContraFect Corp (CFRXQ) stock worth over $1. Details can be seen in Roger Pomerantz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roger Pomerantz has not made any transactions after 2018-09-07 and currently still holds the listed stock(s).
Transaction Summary of Roger Pomerantz
Roger Pomerantz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roger Pomerantz owns 6 companies in total, including Intec Parent Inc (NTEC) , ContraFect Corp (CFRXQ) , and Seres Therapeutics Inc (MCRB) among others .
Click here to see the complete history of Roger Pomerantz’s form 4 insider trades.
Insider Ownership Summary of Roger Pomerantz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTEC | Intec Parent Inc | 2020-07-15 | director |
| CFRXQ | ContraFect Corp | 2017-07-25 | director |
| MCRB | Seres Therapeutics Inc | 2018-09-07 | director & President and CEO |
| RUBY | Rubius Therapeutics Inc | 2018-07-20 | director |
| VIRX | Viracta Therapeutics Inc | 2021-02-24 | director |
| INDP | Indaptus Therapeutics Inc | 2021-07-23 | director |
Roger Pomerantz Latest Holdings Summary
Roger Pomerantz currently owns a total of 3 stocks. Among these stocks, Roger Pomerantz owns 213,976 shares of Seres Therapeutics Inc (MCRB) as of September 7, 2018, with a value of $158,770 and a weighting of 100%. Roger Pomerantz owns 100 shares of Rubius Therapeutics Inc (RUBY) as of July 20, 2018, with a value of $6 and a weighting of 0%. Roger Pomerantz also owns 80 shares of ContraFect Corp (CFRXQ) as of July 25, 2017, with a value of $1 and a weighting of 0%.
Latest Holdings of Roger Pomerantz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2018-09-07 | 213,976 | 0.74 | 158,770 |
| RUBY | Rubius Therapeutics Inc | 2018-07-20 | 100 | 0.06 | 6 |
| CFRXQ | ContraFect Corp | 2017-07-25 | 80 | 0.02 | 1 |
Holding Weightings of Roger Pomerantz
Roger Pomerantz Form 4 Trading Tracker
According to the SEC Form 4 filings, Roger Pomerantz has made a total of 0 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years. The most-recent trade in Seres Therapeutics Inc is the sale of 1,810 shares on September 7, 2018, which brought Roger Pomerantz around $16,290.
According to the SEC Form 4 filings, Roger Pomerantz has made a total of 0 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 100 shares on July 20, 2018, which cost Roger Pomerantz around $2,300.
According to the SEC Form 4 filings, Roger Pomerantz has made a total of 0 transactions in ContraFect Corp (CFRXQ) over the past 5 years. The most-recent trade in ContraFect Corp is the acquisition of 80 shares on July 25, 2017, which cost Roger Pomerantz around $992.
Insider Trading History of Roger Pomerantz
- 1
Roger Pomerantz Trading Performance
GuruFocus tracks the stock performance after each of Roger Pomerantz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roger Pomerantz is -27.33%. GuruFocus also compares Roger Pomerantz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roger Pomerantz within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Roger Pomerantz's insider trading performs compared to the benchmark.
Performance of Roger Pomerantz
Average Return
17.21%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.29 | -27.33 | -26.88 | 17.21 | -46.35 | -13.47 |
| Relative Return to S&P 500(%) | -11.59 | -28.34 | -31.85 | 6.65 | -55.27 | -25.79 |
Roger Pomerantz Ownership Network
Ownership Network List of Roger Pomerantz
Ownership Network Relation of Roger Pomerantz
Roger Pomerantz Owned Company Details
What does Intec Parent Inc do?
Who are the key executives at Intec Parent Inc?
Roger Pomerantz is the director of Intec Parent Inc. Other key executives at Intec Parent Inc include Chief Business Officer Walt Addison Linscott , Chief Financial Officer Nir Sassi , and Chief Operating Officer Nadav Navon .
Intec Parent Inc (NTEC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intec Parent Inc (NTEC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intec Parent Inc (NTEC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intec Parent Inc (NTEC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intec Parent Inc Insider Transactions
Roger Pomerantz Mailing Address
Above is the net worth, insider trading, and ownership report for Roger Pomerantz. You might contact Roger Pomerantz via mailing address: 711 Harvest Hill Road, Chalfont Pa 18914.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
